These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

358 related items for PubMed ID: 27053857

  • 1. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
    Yang JF, Zhao ZH, Zhang Y, Zhao L, Yang LM, Zhang MM, Wang BY, Wang T, Lu BC.
    World J Gastroenterol; 2016 Apr 07; 22(13):3652-62. PubMed ID: 27053857
    [Abstract] [Full Text] [Related]

  • 2. A comparison of tracer kinetic models for T1-weighted dynamic contrast-enhanced MRI: application in carcinoma of the cervix.
    Donaldson SB, West CM, Davidson SE, Carrington BM, Hutchison G, Jones AP, Sourbron SP, Buckley DL.
    Magn Reson Med; 2010 Mar 07; 63(3):691-700. PubMed ID: 20187179
    [Abstract] [Full Text] [Related]

  • 3. Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer.
    Kallehauge JF, Tanderup K, Duan C, Haack S, Pedersen EM, Lindegaard JC, Fokdal LU, Mohamed SM, Nielsen T.
    Acta Oncol; 2014 Aug 07; 53(8):1064-72. PubMed ID: 25034348
    [Abstract] [Full Text] [Related]

  • 4. DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model--initial experience.
    Jajamovich GH, Huang W, Besa C, Li X, Afzal A, Dyvorne HA, Taouli B.
    MAGMA; 2016 Feb 07; 29(1):49-58. PubMed ID: 26646522
    [Abstract] [Full Text] [Related]

  • 5. Dynamic Contrast-Enhanced MRI Kinetic Parameters as Prognostic Biomarkers for Prediction of Survival of Patient with Advanced Hepatocellular Carcinoma: A Pilot Comparative Study.
    Lee SH, Hayano K, Zhu AX, Sahani DV, Yoshida H.
    Acad Radiol; 2015 Nov 07; 22(11):1344-60. PubMed ID: 26211553
    [Abstract] [Full Text] [Related]

  • 6. Correlation of radiomic features on dynamic contrast-enhanced magnetic resonance with microvessel density in hepatocellular carcinoma based on different models.
    Liang H, Hu C, Lu J, Zhang T, Jiang J, Ding D, Du S, Duan S.
    J Int Med Res; 2021 Mar 07; 49(3):300060521997586. PubMed ID: 33682491
    [Abstract] [Full Text] [Related]

  • 7. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J, Nielsen T, Haack S, Peters DA, Mohamed S, Fokdal L, Lindegaard JC, Hansen DC, Rasmussen F, Tanderup K, Pedersen EM.
    Acta Oncol; 2013 Oct 07; 52(7):1360-8. PubMed ID: 24003852
    [Abstract] [Full Text] [Related]

  • 8. Validation of Blood Volume Fraction Quantification with 3D Gradient Echo Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscle.
    Hindel S, Söhner A, Maaß M, Sauerwein W, Möllmann D, Baba HA, Kramer M, Lüdemann L.
    PLoS One; 2017 Oct 07; 12(1):e0170841. PubMed ID: 28141810
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of tumor microvascular response to brivanib by dynamic contrast-enhanced 7-T MRI in an orthotopic xenograft model of hepatocellular carcinoma.
    Song KD, Choi D, Lee JH, Im GH, Yang J, Kim JH, Lee WJ.
    AJR Am J Roentgenol; 2014 Jun 07; 202(6):W559-66. PubMed ID: 24848850
    [Abstract] [Full Text] [Related]

  • 10. Validation of Interstitial Fractional Volume Quantification by Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Porcine Skeletal Muscles.
    Hindel S, Söhner A, Maa M, Sauerwein W, Baba HA, Kramer M, Lüdemann L.
    Invest Radiol; 2017 Jan 07; 52(1):66-73. PubMed ID: 27482651
    [Abstract] [Full Text] [Related]

  • 11. Dual-input tracer kinetic modeling of dynamic contrast-enhanced MRI in thoracic malignancies.
    Lee SH, Rimner A, Deasy JO, Hunt MA, Tyagi N.
    J Appl Clin Med Phys; 2019 Nov 07; 20(11):169-188. PubMed ID: 31602789
    [Abstract] [Full Text] [Related]

  • 12. Comparative study of methods for determining vascular permeability and blood volume in human gliomas.
    Harrer JU, Parker GJ, Haroon HA, Buckley DL, Embelton K, Roberts C, Balériaux D, Jackson A.
    J Magn Reson Imaging; 2004 Nov 07; 20(5):748-57. PubMed ID: 15503330
    [Abstract] [Full Text] [Related]

  • 13. Application of Distributed Parameter Model to Assessment of Glioma IDH Mutation Status by Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Li Z, Zhao W, He B, Koh TS, Li Y, Zeng Y, Zhang Z, Zhang J, Hou Z.
    Contrast Media Mol Imaging; 2020 Nov 07; 2020():8843084. PubMed ID: 33299387
    [Abstract] [Full Text] [Related]

  • 14. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
    Nadav G, Liberman G, Artzi M, Kiryati N, Bashat DB.
    J Magn Reson Imaging; 2017 Jan 07; 45(1):237-249. PubMed ID: 27383624
    [Abstract] [Full Text] [Related]

  • 15. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
    Li Z, Sun J, Chen L, Huang N, Hu P, Hu X, Han G, Zhou Y, Bai W, Niu T, Yang X.
    J Magn Reson Imaging; 2016 Jul 07; 44(1):98-104. PubMed ID: 26707910
    [Abstract] [Full Text] [Related]

  • 16. Multiphasic Dynamic Computed Tomography Evaluation of Liver Tissue Perfusion Characteristics Using the Dual Maximum Slope Model in Patients With Cirrhosis and Hepatocellular Carcinoma: A Feasibility Study.
    Lee DH, Lee JM, Klotz E, Han JK.
    Invest Radiol; 2016 Jul 07; 51(7):430-4. PubMed ID: 26756941
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic Analysis of Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Distinguishing Hepatocellular Carcinoma From Cholangiocarcinoma in Pre-Liver Transplantation Evaluation.
    Lin CC, Cheng YF, Chiang HJ, Lazo M, Chang CD, Tsang LL, Yu CY, Hsu HW, Chen WT, Wang CC, Liang JL, Eng HL, Chen CL, Ou HY.
    Transplant Proc; 2016 May 07; 48(4):1041-4. PubMed ID: 27320551
    [Abstract] [Full Text] [Related]

  • 18. Dynamic contrast-enhanced magnetic resonance imaging measurements in renal cell carcinoma: effect of region of interest size and positioning on interobserver and intraobserver variability.
    Braunagel M, Radler E, Ingrisch M, Staehler M, Schmid-Tannwald C, Rist C, Nikolaou K, Reiser MF, Notohamiprodjo M.
    Invest Radiol; 2015 Jan 07; 50(1):57-66. PubMed ID: 25260094
    [Abstract] [Full Text] [Related]

  • 19. Endometrial carcinoma: use of tracer kinetic modeling of dynamic contrast-enhanced MRI for preoperative risk assessment.
    Ye Z, Ning G, Li X, Koh TS, Chen H, Bai W, Qu H.
    Cancer Imaging; 2022 Mar 09; 22(1):14. PubMed ID: 35264244
    [Abstract] [Full Text] [Related]

  • 20. Dynamic contrast-enhanced MRI differentiates hepatocellular carcinoma from hepatic metastasis of rectal cancer by extracting pharmacokinetic parameters and radiomic features.
    Li J, Xue F, Xu X, Wang Q, Zhang X.
    Exp Ther Med; 2020 Oct 09; 20(4):3643-3652. PubMed ID: 32855716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.